Bank of New York Mellon
FBRX icon

Bank of New York Mellon’s Forte Biosciences FBRX Stock Holding History

Bank of New York Mellon’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$870K Buy
+40,930
New +$971K ﹤0.01% 3449
2022
Q2 		– Sell
-1,244
Closed -$46K – 4632
2022
Q1 		$46K Hold
1,244
– – ﹤0.01% 4535
2021
Q4 		$67K Sell
1,244
-150
-11% -$10.1K ﹤0.01% 4459
2021
Q3 		$103K Buy
1,394
+290
+26% +$161K ﹤0.01% 4330
2021
Q2 		$928K Buy
+1,104
New +$995K ﹤0.01% 3469
2021
Q1 		– Sell
-234
Closed -$213K – 4335
2020
Q4 		$213K Buy
+234
New +$220K ﹤0.01% 3957
2020
Q2 		– Sell
-120
Closed -$55K – 4111
2020
Q1 		$55K Hold
120
– – ﹤0.01% 3959
2019
Q4 		$24K Sell
120
-43
-26% -$9.74K ﹤0.01% 4148
2019
Q3 		$41K Sell
163
-32
-16% -$48.6K ﹤0.01% 4140
2019
Q2 		$489K Buy
195
+31
+19% +$91.9K ﹤0.01% 3618
2019
Q1 		$667K Buy
164
+12
+8% +$46.4K ﹤0.01% 3407
2018
Q4 		$468K Buy
152
+11
+8% +$47.4K ﹤0.01% 3519
2018
Q3 		$824K Buy
141
+16
+13% +$60.9K ﹤0.01% 3380
2018
Q2 		$438K Sell
125
-17
-12% -$62.3K ﹤0.01% 3686
2018
Q1 		$630K Buy
142
+4
+3% +$18.5K ﹤0.01% 3463
2017
Q4 		$532K Buy
138
+65
+89% +$259K ﹤0.01% 3597
2017
Q3 		$343K Buy
73
+11
+18% +$49K ﹤0.01% 3713
2017
Q2 		$281K Buy
+62
New +$349K ﹤0.01% 3835

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
WC
Weil Company San Diego, California $568M AUM 19.88% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon's FBRX Position: Q2 2026 in Review

Bank of New York Mellon opened a new position in Forte Biosciences (FBRX) in Q2 2026: 40,930 shares worth $870K. The stake represents ﹤0.01% of the portfolio and ranks #3449 among its holdings. This is a return to the name: Bank of New York Mellon previously reported a position in FBRX as recently as Q1 2022.

Bank of New York Mellon first reported a position in FBRX in Q2 2017 and has held it in 18 quarters since. The position peaked at $928K in Q2 2021. 29 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

  • Bank of New York Mellon held 40,930 shares of Forte Biosciences worth $870K as of Q2 2026.
  • Forte Biosciences was a new Bank of New York Mellon position in Q2 2026.
  • Forte Biosciences made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3449 holding.
  • Bank of New York Mellon first reported a position in Forte Biosciences in Q2 2017 and has held it in 18 quarters since.
  • Bank of New York Mellon's Forte Biosciences position peaked at $928K in Q2 2021.
  • 29 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.